HTML Issue

Volume 13 Issue 5 (May) 2024

Original Articles

Efficacy of intravaginal misoprostol v/s dinoprostone vaginal insert in induction of labour- A comparative open label randomised study
Dr. Apoorva Malhotra, Dr. Navneet Kaur

Background: Induction of labour being a routine obstetric practice warrants the need to conduct more and more studies for the advancement of the techniques which aid it .Prostaglandins are a common method of induction of labor. In our study, we compare cervical ripening with intravaginal prostaglandin E1 analogue and the comparitively newer intravaginal prostaglandin E2 pessary with regard to induction delivery interval, mode of delivery, efficacy, safety, along with maternal outcomes of induction. Materials and methods: 100 Patients admitted in OBG Department of ASCOMS Hospita jammu with an indication for induction of labour from October 2021 to October 2022 who fulfilled the inclusion and exclusion criteria were included in the study.50 patients were induced with 25µg of intravaginal misoprostol. Rest 50 patients were administered 10 mg intravaginal dinoprostone pessary (insert). the efficacy was compared with respect toInduction delivery interval, Oxytocin Augmentation,Type of delivery, Cost effectivenes and maternal outcome. Results: Misoprostol is more cost-effective and stable at room temperature and has lesser Induction delivery interval and requirement of Oxytocin augmentation than dinoprostoneHowever with dinoprostone the vaginal delivery rate is high , need for caesarean section is less,uterine tachysystole and hyperstimulation rate is lesser than with misoprostol. Conclusion: Dinoprostone pessary, is a safe, efficient and a reliable induction agent which may become the method and drug of choice, for induction of labour in the coming years.

 
Abstract View | Download PDF | Current Issue

Get In Touch

IJLBPR

322 Parlount Road Slough Berkshire SL3 8AX, UK

ijlbpr@gmail.com

Submit Article

© IJLBPR. All Rights Reserved.